Peng Chen
Impact in
- Cancer Research top 1%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Immunology top 2%
- Immune cells in cancer
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
Papers in
-
- Molecular Biology Techniques and Applications 14
- RNA modifications and cancer 13
- Circular RNAs in diseases 9
-
- Cancer-related molecular mechanisms research 23
- MicroRNA in disease regulation 21
- Cancer Genomics and Diagnostics 11
- Co-authors
- Qiyi Zhao (5 shared papers)Dong‐Ming Kuang (5 shared papers)Limin Zheng (4 shared papers)Yan Wu (4 shared papers)Jing‐Ping Zhang (1 shared paper)Changyou Wu (1 shared paper)Jing Xu (1 shared paper)Jianen Wang (2 shared papers)
- Journals
- BMC Cancer (6 papers)Oncotarget (6 papers)Forensic Science International (5 papers)Forensic Science International Genetics (5 papers)Legal Medicine (4 papers)
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Peng Chen
258 papers receiving 5.4k citations
Peng Chen's Hit Papers
Peers
Comparison fields: 5 of 160
- Cancer Research 1.1k
- Immunology 1.5k
- Oncology 1.6k
- Hepatology 251
- Molecular Biology 2.1k
Countries citing papers authored by Peng Chen
This map shows the geographic impact of Peng Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peng Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peng Chen more than expected).
Fields of papers citing papers by Peng Chen
This network shows the impact of papers produced by Peng Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peng Chen. The network helps show where Peng Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Peng Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 279 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1 Hit paper breakdown → | 2009 | 718 |
| 2 | 2010 | 401 | |
| 3 | 2009 | 220 | |
| 4 | 2018 | 173 | |
| 5 | 2010 | 129 | |
| 6 | 2011 | 119 | |
| 7 | 2021 | 114 | |
| 8 | 2011 | 87 | |
| 9 | 2008 | 75 | |
| 10 | 2020 | 71 | |
| 11 | 2021 | 68 | |
| 12 | 2019 | 65 | |
| 13 | 2021 | 58 | |
| 14 | 1998 | 57 | |
| 15 | 2021 | 50 | |
| 16 | 2017 | 49 | |
| 17 | 2019 | 49 | |
| 18 | 2016 | 49 | |
| 19 | 2018 | 48 | |
| 20 | 2023 | 47 |
About Peng Chen
Peng Chen is a scholar working on Molecular Biology, Cancer Research, Oncology, Surgery and Pulmonary and Respiratory Medicine, having authored 279 papers that have together received 5.4k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (23 papers), MicroRNA in disease regulation (21 papers), Forensic and Genetic Research (15 papers), Molecular Biology Techniques and Applications (14 papers), RNA modifications and cancer (13 papers), Cancer Immunotherapy and Biomarkers (12 papers), Cancer Genomics and Diagnostics (11 papers) and Circular RNAs in diseases (9 papers). The work is most often cited by research in Cancer Research (1.1k citations), Immunology (1.5k citations), Oncology (1.6k citations), Hepatology (251 citations) and Molecular Biology (2.1k citations). Peng Chen has collaborated with scholars based in China, United States and France. Frequent co-authors include Qiyi Zhao, Dong‐Ming Kuang, Limin Zheng, Yan Wu, Jing‐Ping Zhang, Changyou Wu, Jing Xu, Jianen Wang, Xiaoyu Yin and Zhenqun Xu. Their work appears in journals such as BMC Cancer, Oncotarget, Forensic Science International, Forensic Science International Genetics and Legal Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.